Eicosapentaenoic acid ethyl ester

CAS: 86227-47-6

Ref. 3D-FE22648

Produktinformation

• Name: Eicosapentaenoic acid ethyl ester
• Synonyme: (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid ethyl ester (all-Z)-5,8,11,14,17-eicosapentaenoic acid ethyl ester, (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid ethyl ester, (all-Z)-5,8,11,14,17-Eicosapentaenoic acid ethyl ester, 5,8,11,14,17-Eicosapentaenoic acid, ethyl ester, (5Z,8Z,11Z,14Z,17Z)-, 5,8,11,14,17-Eicosapentaenoic acid, ethyl ester, (all-Z)-, Amr 101, C20:5 n-3 Ethyl ester, Epadel, Epadel S 300, Ethyl (5E,8E,11E,14E,17E)-5,8,11,14,17-icosapentaenoate, Ethyl (5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenoate, Ethyl 5,8,11,14,17-icosapentaenoate, Ethyl all-Z-5,8,11,14,17-eicosapentanenoate, Ethyl all-cis-5,8,11,14,17-eicosapentaenoate, Ethyl eicosapentaenoate, Ethyl icosapentate, Icosapent ethyl, Incromega EPA, Timnodonic acid ethyl ester, Vascepa, cis-Eicosapentaenoic acid ethyl ester

Beschreibung

Eicosapentaenoic acid ethyl ester (EPA-E) is a natural compound that belongs to the group of polyunsaturated fatty acids. EPA-E has been shown to be an antioxidant, which prevents oxidative damage and reduces inflammation. It has been found to lower LDL cholesterol and triglycerides in clinical trials. EPA-E also decreases body mass index, hepatic steatosis, and symptoms of metabolic syndrome. The mechanism of action for these effects is not fully understood but may be due to increased activity of the enzyme spal2. EPA-E has been shown to have favorable biochemical properties in animal models of atherosclerosis.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 330.5 g/mol
• Formel: C₂₂H₃₄O₂
• Reinheit: Min. 96 Area-%
• Farbe/Form: Clear Liquid
• InChl: InChI=1S/C22H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17-
• InChI Key: InChIKey=SSQPWTVBQMWLSZ-AAQCHOMXSA-N
• SMILES: CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC